Merrill puts Applied Biosystems at neutral

Applied Biosystems was rated at neutral by Merrill Lynch analyst Darryl Pardi. The company reported earnings per share of $0.34, $0.06 above Merrill's estimate and $0.04 ahead of consensus. Organic revenues grew 6% excluding the royalty and license fees, nearly three times what the analyst had forecasted. Merrill's earnings per share estimate for 2006 is $1.23, and $1.22 for 2008. Shares of the Foster City, Calif., scientific products company were up $1.37, or 5.05%, at $28.50 on volume of 2,304,600 shares versus the three-month running average of 958,668 shares. (NYSE: ABI)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.